Maladies cardiovasculaires : un médicament à l’essai pour prévenir de la sténose aortique 👇
Lire le communiqué : presse.inserm.fr/maladies-car...
@chulille.bsky.social @univlille.bsky.social
Very proud to be invited to the RFHT journal for the Year of hemostasis. Was an amazing experience. #rfht
🔬 Sténose aortique : un traitement médicamenteux ?
L’équipe des Prs Susen et Van Belle a identifié une nouvelle piste thérapeutique : l’acide rétinoïque, qui pourrait ralentir la calcification de la valve aortique.
Ce médicament offrirait une alternative au remplacement valvulaire 🫀.
Congratulations to @melaniedaniel.bsky.social MD at CHU de Lille and at UMR1011 team 2, led by Pr @sophiesusen.bsky.social) for her great presentation at the European Congress on Thrombosis and Haemostasis :
“Unbiased assessment of VWD burden and healthcare consumption using pseudonymized big data.”
Congrats to @mickaelrosa.bsky.social and Pr Antoine Rauch on winning the Bernd R. Binder publication prize at ECTH for their 2023 paper : role of ECMO-associated shear forces on GPIba shedding resulting in platelet clearance and thrombocytopenia.
Team 2 Pr @sophiesusen.bsky.social, UMR1011
Amazing presentation by @rociovacikdiaz.bsky.social at European Congress on Thrombosis and Haemostasis (ECTH) 2025: impact of LVAD implantation on circulating proteome with a focus on the early dynamic changes. Work from Team 2 led by Professor @sophiesusen.bsky.social , UMR1011
We are honored to welcome @riittalassila.bsky.social to Paris for the French Society of Hematology's talk on Red Blood Cells in Hemostasis. Thank you! #sfh #sfth #hemsky #hemesky
Wonderful presentation by @mickaelrosa.bsky.social in the Science Fast and Furious session at ECTH2025 in Prague : effect of emicizumab focusing on monocytes/macrophages using single cell and transcriptomic data. Work from team 2 led by Professor @sophiesusen.bsky.social, UMR1011.
Plenary session at the SFH with Prof. Marie-Christine Alessi invited for a talk on phenotype/genotype in platelet disorders with Hana Raslova as moderator. #hemesky #hemsky #sfh
Sophie Susen
Alex K
CHU de Lille
Inserm
Société Française de Thrombose et d'Hémostase
Société Française de Thrombose et d'Hémostase
A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose blood thinners. #NEJM
www.nejm.org/doi/full/10....
Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is associated with antibodies
that target platelet factor 4 (PF4) and are heparin-independent. VITT antibodies are
implicated in acute,...
